Clinical Trial Update: Treatment Optimization in Patients With Untreated Multiple Myeloma [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial update on treatment optimization for untreated multiple myeloma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Dr. med. Lars-Olof Muegge | Conditions: Multiple Myeloma | Phase 2, Phase 3 | Status: TERMINATED